Clinical Trials in Colorado

Showing 5201-5220 of 13,761 trials

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

NCT05759208

The objective of this study is to compare the safety and efficacy of OK-101 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

Dry Eye Disease

Okyo Pharma Ltd240 participantsStarted Apr 2023

Newport Beach, California, United States • Colorado Springs, Colorado, United States • Louisville, Kentucky, United States +3 more locations

TERMINATEDPhase 348 miles

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

NCT04844749

To demonstrate the efficacy of VERU-111 (Sabizabulin) in the treatment of metastatic castration-resistant prostate cancer in patients who have failed prior treatment with at least one androgen receptor targeting agent as measured by radiographic progression-free survival.

Metastatic Castration-resistant Prostate CancerAndrogen Resistant Prostatic Cancer

Veru Inc.105 participantsStarted Jun 2021

Anchorage, Alaska, United States • Tucson, Arizona, United States • Tucson, Arizona, United States +37 more locations

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting Agent

Find Trials by Condition in Colorado

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Registry of CytoSorb Therapy in COVID-19 ICU Patients

Pleconaril Enteroviral Sepsis Syndrome

ILLUMENATE Pivotal Post-Approval Study (PAS)

A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure

Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries

Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria

Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL

Actuate 1901: 9-ING-41 in Myelofibrosis

A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA